Metraipolis › archive › dc_1ca2ce019125

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms — Europe PMC PMID:42243349

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42243349
DOI
10.1038/s41416-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-08T00:57:44.124Z
SHA-256 of the archived text
8848f087f1072ee2a28fb1182950e95e893a26cb1cb383aee78cc6346917a4b6
Stable URL of this page
https://metraipolis.com/documento/dc_1ca2ce019125

How to cite

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms — Europe PMC PMID:42243349 — Europe PMC (en), https://europepmc.org/article/MED/42243349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ca2ce019125 (Metraipolis archive dc_1ca2ce019125, sha256 8848f087f1072ee2a28fb1182950e95e893a26cb1cb383aee78cc6346917a4b6)
BibTeX
@misc{dc1ca2ce019125,
  title = {A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms — Europe PMC PMID:42243349},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42243349},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ca2ce019125; sha256 8848f087f1072ee2a28fb1182950e95e893a26cb1cb383aee78cc6346917a4b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42243349. Agents can read the archived copy with the MCP tool read_document.